IFNA1 and melanoma: Although the effect of SOCS1 or other SOCS family members (i.e. SOCS3) on IFN-α-responsiveness of melanoma cells was not evaluated in this prior study, our observations suggest that SOCS1 and SOCS3 could be a clinically relevant inhibitor of cytokine action.